{
  "pmid": "PMID:32642736",
  "title": "Management of cutaneous neurofibroma: current therapy and future directions.",
  "abstract": "Neurofibromatosis type 1 (NF1) is a life-long neurocutaneous disorder characterized by a predisposition to tumor development, including cutaneous neurofibroma (cNF), the hallmark of the disease. cNF is a histologically benign, multicellular tumor formed in virtually most individuals with NF1. It is considered the most burdensome feature of the disorder due to their physical discomfort, cosmetically disfiguring appearance, and psychosocial burden. Management of cNF remains a challenge in the medical field. Effective medicinal treatment for cNF does not exist at this time. Trials aimed at targeting individual components of the neoplasm such as mast cells with Ketotifen have not shown much success. Physical removal or destruction has been the mainstay of therapy. Surgical removal gives excellent cosmetic results, but risk in general anesthesia may require trained specialists. Destructive laser such as CO",
  "authors": "Bahir H Chamseddin; Lu Q Le",
  "journal": "Neuro-oncology advances",
  "publicationDate": "2020-07",
  "doi": "10.1093/noajnl/vdz034",
  "methods": "",
  "cache_level": "abstract_only",
  "has_fulltext": false,
  "fetch_date": "2026-02-20 06:58:24"
}